EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Factors Impacting Access and Engagement of Cognitive Remediation Therapy for People with Schizophrenia: A Systematic Review

Rosalie Ariane Eva Altman iD, Eric Josiah Tan, Susan Lee Rossell

The Canadian Journal of Psychiatry · 2023-03 · 68 (3) · 139-151

DOI: 10.1177/07067437221129073 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Canadian Journal of Psychiatry, online erschienen am 29.11.2022. Verfasst von Rosalie Ariane Eva Altman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Mental Health, School of Health Sciences, 3783Swinburne University of Technology, Melbourne, Australia. Hauptthemen laut MEDLINE: Schizophrenia, Cognitive Remediation, Cognitive Behavioral Therapy. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Swinburne University of Technology, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Neurocognitive deficits are central in schizophrenia. Cognitive remediation has proven effective in alleviating these deficits, with medium effect sizes. However, sizeable attrition rates are reported, with the reasons still uncertain. Furthermore, cognitive remediation is not part of routine mental health care. We conducted a systematic review to investigate factors that influence access and engagement of cognitive remediation in schizophrenia.

Methods

We systematically searched the PubMed, Web of Science, and PsycINFO databases for peer-reviewed articles including a cognitive remediation arm, access, and engagement data, and participants with schizophrenia spectrum disorders aged 17–65 years old. Duplicates and studies without a distinct cognitive remediation component, protocol papers, single case studies, case series, and reviews/meta-analyses were excluded.

Results

We included 67 studies that reported data on access and engagement, and extracted quantitative and qualitative data. Access data were limited, with most interventions delivered on-site, to outpatients, and in middle- to high-income countries. We found a median dropout rate of 14.29%. Only a small number of studies explored differences between dropouts and completers ( n = 5), and engagement factors ( n = 13). Dropouts had higher negative symptomatology and baseline self-efficacy, and lower baseline neurocognitive functioning and intrinsic motivation compared to completers. The engagement was positively associated with intrinsic motivation, self-efficacy, perceived usefulness, educational level, premorbid intelligence quotient, baseline neurocognitive functioning, some neurocognitive outcomes, and therapeutic alliance; and negatively associated with subjective cognitive complaints. Qualitative results showed good acceptability of cognitive remediation, with some areas for improvement.

Conclusions

Overall, access and engagement results are scarce and heterogeneous. Further investigations of cognitive remediation for inpatients, as well as remote delivery, are needed. Future clinical trials should systematically explore attrition and related factors. Determining influential factors of access and engagement will help improve the implementation and efficacy of cognitive remediation, and thus the recovery of people with schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaCognitive RemediationCognitive Behavioral TherapyHumansAdolescentYoung AdultAdultMiddle AgedAgedSelf Efficacy

Stichwörter der Autor:innen

clinical trialcognitive remediationhealth services accessibilityschizophreniatreatment adherence and compliance

Autor:innen und Institutionen

  • Centre for Mental Health, School of Health Sciences, 3783Swinburne University of Technology, Melbourne, Australia.
  • Department of Mental Health, 60078St Vincent's Hospital, Melbourne, Australia.

ORCID-Profile: Rosalie Ariane Eva Altman

Förderung

  • Swinburne University of Technology
  • National Health and Medical Research Council

Zitieren

APA

Altman, R. A. E., Tan, E. J., & Rossell, S. L. (2023). Factors Impacting Access and Engagement of Cognitive Remediation Therapy for People with Schizophrenia: A Systematic Review. The Canadian Journal of Psychiatry, 68(3), 139-151. https://doi.org/10.1177/07067437221129073

Vancouver

Altman RAE, Tan EJ, Rossell SL. Factors Impacting Access and Engagement of Cognitive Remediation Therapy for People with Schizophrenia: A Systematic Review. The Canadian Journal of Psychiatry. 2023;68(3):139-151. doi:10.1177/07067437221129073

BibTeX
@article{Altman2023,
  author = {Altman, Rosalie Ariane Eva and Tan, Eric Josiah and Rossell, Susan Lee},
  title = {Factors Impacting Access and Engagement of Cognitive Remediation Therapy for People with Schizophrenia: A Systematic Review},
  journal = {The Canadian Journal of Psychiatry},
  year = {2023},
  volume = {68},
  number = {3},
  pages = {139--151},
  doi = {10.1177/07067437221129073}
}
Kostenlos starten →